CYCLURAD Trademark

Trademark Overview

On Friday, July 9, 2021, a trademark application was filed for CYCLURAD with the United States Patent and Trademark Office. The USPTO has given the CYCLURAD trademark a serial number of 90819317. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 13, 2024. This trademark is owned by NeuroRx, Inc.. The CYCLURAD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of depression
cyclurad

General Information

Serial Number90819317
Word MarkCYCLURAD
Filing DateFriday, July 9, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 15, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of depression

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 16, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNeuroRx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWilmington, DE 19801
US
Party NameNeuroRx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilmington, DE 19801
US

Trademark Events

Event DateEvent Description
Tuesday, July 13, 2021NEW APPLICATION ENTERED
Thursday, September 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 11, 2022ASSIGNED TO EXAMINER
Tuesday, January 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 15, 2022PUBLISHED FOR OPPOSITION
Tuesday, February 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 20, 2022TEAS PETITION TO REVIVE RECEIVED
Thursday, October 20, 2022PETITION TO REVIVE-GRANTED
Thursday, October 20, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, October 20, 2022NOTICE OF REVIVAL - E-MAILED
Monday, November 21, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 12, 2022SOU EXTENSION 1 FILED
Tuesday, November 22, 2022SOU EXTENSION 1 GRANTED
Wednesday, November 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 20, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 20, 2023SOU EXTENSION 2 FILED
Monday, March 20, 2023SOU EXTENSION 2 GRANTED
Wednesday, March 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 11, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 11, 2023SOU EXTENSION 3 FILED
Wednesday, October 11, 2023SOU EXTENSION 3 GRANTED
Friday, October 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 13, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, May 13, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

cyclurad depression treatment preparations pharmaceutical